The Side Effects and Correlates of OROS-Methylphenidate in the Treatment of Children and Adolescents with ADHD
![]() |
Kim, Jin-Sun
(Department of Psychiatry, Seoul National University Hospital)
Kim, Bung-Nyun (Department of Psychiatry, Seoul National University Hospital) Cho, Soo-Churl (Department of Psychiatry, Seoul National University Hospital) Shin, Min-Sup (Department of Psychiatry, Seoul National University Hospital) Yoo, Hee-Jeong (Department of Psychiatry, Seoul National University Bundang Hospital) Kim, Jae-Won (Department of Psychiatry, Seoul National University Hospital) Song, Dong-Ho (Department of Psychiatry and The Institute of Behavioral Science in Medicine, Yonsei University College of Medicine) Shin, Dong-Won (Department of Psychiatry, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospita) Joung, Yoo-Sook (Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center) Cheon, Keun-Ah (Department of Psychiatry, Kwandong University College of Medicine, Myong-Ji Hospital) Shin, Yee-Jin (Department of Psychiatry and The Institute of Behavioral Science in Medicine, Yonsei University College of Medicine) Kim, Ye-Ni (Department of Psychiatry, Seoul National Hospital) Ha, Eun-Hye (Department of Child Welfare, Sookmyung Women's University) |
1 | Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 2001;40:525-529. DOI ScienceOn |
2 | Brown RT, Sexson SB. Effects of methylphenidate on cardiovascular- responses in attention deficit hyperactivity disordered adolescents. J Adolesc Health 1989;10:179-183. DOI |
3 | Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 1984;45:473-476. |
4 | Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 2005;44:1015-1023. DOI ScienceOn |
5 | Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol 2006;13:50-62. |
6 | Cho SC, Choi JS. Development of the Korean Form of the State- Trait Anxiety Inventory for Children. Seoul J Psychiatry 1989;14: 150-157. |
7 | Cho SC. A multi-center, open label study to evaluate safe and effective doses of OROS-MPH. Spring Meeting of the Korea Academy of Child and Adolescent Psychitry; 2004 May 14-15; Gyeongju, Korea. Seoul: Korea Academy of Child and Adolescent Psychietry;2004. |
8 | Stein MA, Blondis TA, Schnitzler ER, OBrien T, Fishkin J, Blackwell B, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996;98:748-756. |
9 | Rapport MD, Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate - a review of height/weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev 2002;22: 1107-1131. DOI ScienceOn |
10 | Fine S, Johnston C. Drug and placebo side-effects in methylphenidate- placebo trial for attention-deficit hyperactivity disorder. Child Psychiatry Hum Dev 1993;24:25-30. DOI |
11 | Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998;94:127-152. DOI ScienceOn |
12 | American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-III. Washington DC: American Psychiatric Association;1980. |
13 | Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100: 662-666. DOI ScienceOn |
14 | Ring A, Stein D, Barak Y, Teicher A, Hadjez J, Elizur A, et al. Sleep disturbances in children with attention-deficit/hyperactivity disorder: A comparative study with healthy siblings. J Learn Disabil 1998;31:572-578. DOI |
15 | Barkley RA, Mcmurray MB, Edelbrock CS, Robbins K. Sideeffects of methylphenidate in children with attention-deficit hyperactivity disorder-a systemic, placebo-controlled evaluation. Pediatrics 1990;86:184-192. |
16 | Klein R, Bessler A. Stimulant side effects in children. In: Lieberman J, ed. Adverse Effects of Psychotropic Drugs. New York: Guilford Press;1992. p.470-496. |
17 | Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 1998;8:13-25. DOI |
18 | Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 2003;112:404-413. DOI ScienceOn |
19 | Karabekiroglu K, Yazgan YM, Dedeoglu C. Can we predict short-term side effects of methylphenidate immediate-release? Int J Psychiaty Clin 2008;12:48-54. DOI ScienceOn |
20 | Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1999;38:402-409. DOI ScienceOn |
21 | Cho SC, Shin MS. Diagnosis and assessment of child psychopathology. Seoul: Hakjisa;2006. |
22 | Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clin Ther 2006;28:1892-1908. DOI ScienceOn |
23 | Kovacs M, Beck AT. An empirical- clinical approach toward a definition of childhood depression. depression in childhood: diagnosis', treatment and conceptual models. New York: Raven Press; 1977. |
24 | Spielberger C. Preliminary manual for the Stait-Trait Anxiety Inventory for Children. Palo Alto: Consulting Psychologist Press; 1973. |
25 | Elia J. Drug treatment for hyperactive children. Therapeutic guidelines. Drugs 1993;46:863-871. DOI ScienceOn |
26 | Anon. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41:26-49. DOI ScienceOn |
27 | Tannock R, Schachar RJ, Carr RP, Logan GD. Dose-response effects of methylphenidate on academic-performance and overt behavior in hyperactive-children. Pediatrics 1989;84: 648-657. |
28 | Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, et al. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 2003;42:424-433. DOI ScienceOn |
29 | Kelly KL, Rapport MD, Dupaul GJ. Attention deficit disorder and methylphenidate-a multi-step analysis of dose-response effects on childrens cardiovascular functioning. Int Clin Psychopharmacol 1988;3:167-181. DOI |
30 | Solanto MV, Conners CK. A dose-response and time-action analysis of autonomic and behavioral-effects of methylphenidate in attention deficit disorder with hyperactivity. Psychophysiology 1982;19:658-667. DOI ScienceOn |
31 | Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Vanerem AJ, Laplant RJ. Placebo-controlled evaluation of ritalin side-effects. Pediatrics 1993;91:1101-1106. |
![]() |